top of page
  • Instagram
  • Facebook
  • X
  • LinkedIn

Urology at Crosswords



ACROSS

6. FDA approved systemic therapy for BCG unresponsive CIS

8. Current standard of care for metastatic papillary RCC

9. Drug shown to improve DFS in adjuvant settings in patients with RCC at high risk for recurrence

10. FDA approved tyrosine kinase inhibitor for metastatic urothelial cancer post platinum chemotherapy

 

DOWN

3. FDA approved antibody-drug conjugate for locally advanced or metastatic urothelial cancer  

4. HIF-2α inhibitor approved by FDA for VHL associated RCC & other tumors

1. FDA approved for mCRPC with deleterious BRCA mutations

7. Monoclonal antibody against carbonic anhydrase IX

2. Oral GnRH antagonist

5. FDA approved for adjuvant treatment in urothelial cancer who are platinum ineligible

8 views0 comments

Comments


North Zone Chapter of Urological Society of India

Twitter

Facebook

LinkedIn

Home

Facebook
Twitter
LinkedIn

Voice Number:  +919897921138

1st Floor, Metro Station, above HDFC Bank, opp. Metro Pillar No.195, Block 1, South Patel Nagar, New Delhi, Delhi 110008

nzusi.org

bottom of page